Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results
Go back to Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.67 | 52 Week High | $1.11 | |||
| Open | $2.66 | 52 Week Low | $0.41 | |||
| Day High | $2.67 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $-0.29 | |||
| Volume | 743,795 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.67 | 52 Week High | $1.11 | |||
| Open | $2.66 | 52 Week Low | $0.41 | |||
| Day High | $2.67 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $-0.29 | |||
| Volume | 743,795 | |||||

